These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 17879530)
1. [Clinical significance of matrix metalloproteinase-9 and tissue factors secreted by cultured monocyte-derived macrophage of patients with coronary heart disease in vitro and the intervenient effect of puerarin on them]. Li DY; Wang ZL; Xia Y Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Aug; 27(8):692-5. PubMed ID: 17879530 [TBL] [Abstract][Full Text] [Related]
2. Pentraxin 3, long expression in mononuclear cells of patients with acute coronary syndrome: Correlation with C-reactive protein and matrix metalloproteinase-9 levels. Ma R; Zhang W; Wang T; He X; Huang Z; Zhu J; Yao Z J Int Med Res; 2014 Jun; 42(3):677-83. PubMed ID: 24709882 [TBL] [Abstract][Full Text] [Related]
3. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease. Brunner S; Kim JO; Methe H Am J Cardiol; 2010 Feb; 105(4):429-34. PubMed ID: 20152234 [TBL] [Abstract][Full Text] [Related]
4. [Effects of PPAR-gamma agonist rosiglitazone on MMP-9 and TIMP-1 expression of monocyte-derived macrophages isolated from patients with acute coronary syndrome]. Luo YM; Wan XH; Jiang DQ; Kuang WY; Guo HB; Chen ZX; Wang HJ; Xie LH; Duan W Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Aug; 37(8):739-45. PubMed ID: 20021931 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of leukotriene b4 and extracellular matrix metalloproteinase inducer in acute coronary syndrome. Xu S; Tang L; Mi Y; Jiang J; Zhu M; Chen B; Wang B; Li T; Xu C; Wang J; Lu X; Ge W; Wang L; Huang J Clin Invest Med; 2013 Dec; 36(6):E282-9. PubMed ID: 24309224 [TBL] [Abstract][Full Text] [Related]
6. Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris. Fukuda D; Shimada K; Tanaka A; Kusuyama T; Yamashita H; Ehara S; Nakamura Y; Kawarabayashi T; Iida H; Yoshiyama M; Yoshikawa J Am J Cardiol; 2006 Jan; 97(2):175-80. PubMed ID: 16442358 [TBL] [Abstract][Full Text] [Related]
7. [Association between serum matrix metalloproteinase-3 concentration and the promoter 5A/6A polymorphism in patients with coronary heart disease]. Gao B; Li ZC Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Sep; 16(9):536-9. PubMed ID: 15355616 [TBL] [Abstract][Full Text] [Related]
8. [Plasma matrix metalloproteinases-2 and -9 levels are elevated in patients with acute coronary syndrome and coronary chronic total occlusion]. Tang QD; Wu PS; Hou YQ; Huang Z; Zhou ZJ; Guo ZG; Xiu JC; Wang YG Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):1004-7. PubMed ID: 19460733 [TBL] [Abstract][Full Text] [Related]
9. Characterization of interleukin-33 and matrix metalloproteinase-28 in serum and their association with disease severity in patients with coronary heart disease. Liu CL; Shen DL; Zhu K; Tang JN; Wang XF; Zhang L; Zhang JY Coron Artery Dis; 2014 Sep; 25(6):498-504. PubMed ID: 24710352 [TBL] [Abstract][Full Text] [Related]
10. [Measurement peripheral blood index related to inflammation and ox-LDL, ox-LDLAb in patients with coronary heart disease and its clinical significance]. Zhou ZX; Qiang H; Ma AQ; Chen H; Zhou P Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 31(2):258-62. PubMed ID: 16706128 [TBL] [Abstract][Full Text] [Related]
11. Correlation between the severity of coronary artery lesions and levels of estrogen, hs-CRP and MMP-9. Guo C; Zhang S; Zhang J; Liu H; Li P; Liu H; Wang Y Exp Ther Med; 2014 May; 7(5):1177-1180. PubMed ID: 24940407 [TBL] [Abstract][Full Text] [Related]
12. Correlation analysis of levels of adiponectin and matrix metalloproteinase-9 with stability of coronary heart disease. Li Y Technol Health Care; 2015; 23 Suppl 1():S95-8. PubMed ID: 26410336 [TBL] [Abstract][Full Text] [Related]
13. [Implications of serum matrix metalloproteinase-8 elevation in patients with acute coronary syndrome]. Qiang H; Zhou ZX; Ma AQ; Cheng H; Zhou P Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):831-3. PubMed ID: 17584650 [TBL] [Abstract][Full Text] [Related]
14. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. Kai H; Ikeda H; Yasukawa H; Kai M; Seki Y; Kuwahara F; Ueno T; Sugi K; Imaizumi T J Am Coll Cardiol; 1998 Aug; 32(2):368-72. PubMed ID: 9708462 [TBL] [Abstract][Full Text] [Related]
15. The relation between plasma tissue factor and oxidized LDL levels in acute coronary syndromes. Emekli-Alturfan E; Basar I; Alturfan AA; Ayan F; Koldas L; Balci H; Emekli N Pathophysiol Haemost Thromb; 2007; 36(6):290-7. PubMed ID: 20224254 [TBL] [Abstract][Full Text] [Related]
16. EFFECT OF RELATIVE GENE EXPRESSION ON PLAQUE VULNERABILITY IN PATIENTS WITH STABLE ANGINA AND PATIENTS WITH ACUTE CORONARY SYNDROME. Chen N; Zhang JY; Yang SZ; Li YD J Biol Regul Homeost Agents; 2015; 29(2):437-41. PubMed ID: 26122234 [TBL] [Abstract][Full Text] [Related]
17. [Effects of naoxintong capsule on the inflammation and prognosis in borderline lesion coronary heart disease patients]. Li SR; Wang TH; Zhang BJ Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 May; 32(5):607-11. PubMed ID: 22679718 [TBL] [Abstract][Full Text] [Related]
18. [Study on interventing effect of puerarin on insulin resistance in patients with coronary heart disease]. Shi WG; Qu L; Wang JW Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 Jan; 22(1):21-4. PubMed ID: 12585165 [TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin E and matrix metalloproteinase-9 in patients with different stages of coronary artery diseases. Jong GP; Wang YF; Tsai FJ; Tsai CH; Wu CL; Liu RH; Hsieh DJ; Ko FY; Huang CY; Lee SD Chin J Physiol; 2007 Dec; 50(6):277-82. PubMed ID: 18442010 [TBL] [Abstract][Full Text] [Related]
20. [Changes in serum level of carboxy-terminal telopeptide of type I collagen in patients with coronary heart disease]. Deng Y; Chen LH; Wang XB; Song XD; Ling YN; Chen AH; Yang PZ; Guo JB; Que DD; Chen GM Nan Fang Yi Ke Da Xue Xue Bao; 2015 Apr; 35(4):506-10. PubMed ID: 25907933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]